Kazatomprom Reports 17 Production Increase in Third Quarter Bolstering Uranium Supply Outlook Salary Growth Outpaces Hourly Wages What It Signals for the Labor Market Lowes Resilience in Housing Downturn Analyst Commends Consistent Execution Superyacht Season Kicks Off in Cannes Luxury Spending and Carbon Debt in Focus Kevin Hassett Highlights Surge in Credit Card Spending Amid Rising Delinquencies and Farm Bankruptcies TD Cowen Raises Walmart Price Target on Grocery Traffic Strength Gentex Corporation GNTX Q1 2026 Earnings EPS Beats Estimates Amid Modest Stock Decline FISI Q1 2026 Earnings Earnings Beat Drives EPS Above Expectations Amid Flat Revenue TXMD Q3 2023 Earnings EPS Misses Estimates by Wide Margin Amidst Operational Challenges Equinor Q1 2026 Earnings Strong EPS Beat Amid Operational Efficiency ASAN Q1 2026 Earnings EPS Beat Surprises Market Stock Surges 4 NTGR Q1 2026 Earnings EPS Surges Past Estimates Despite Revenue NonDisclosure VisionWave Holdings Warrants VWAVW Edge Higher as Stock Tests Key Resistance EuroDry Ltd EDRY Recedes 37 as Dry Bulk Shipping Faces Headwinds Safe Bulkers Inc SB Slides Nearly 4 as Shipping Sector Faces Renewed Pressure Terra Property Trust Notes TPTA Hold Steady at 2285 as Support and Resistance Levels Define Range Highway Holdings Limited HIHO Consolidates Near 075 as Market Awaits Catalyst Robotop How Advanced Sewing Machines Could Reshape Global Garment Manufacturing Firefly Aerospace Inc FLY Q1 2026 Earnings Narrower Loss Surprises as Stock Soars on Cost Management Rain Enhancement Technologies RAIN Climbs 649 on Renewed Trading Interest KB Financial Group Inc KB Edges Higher Navigating a Tight Trading Range AN2 Therapeutics ANTX Rallies 5 as Bulls Test Critical Resistance at 540 mondaycom MNDY Surges 367 as Momentum Builds Toward Key Resistance YSX Tech Co Ltd YSXT Holds Steady at 103 as Stock Consolidates Near Key Support Natuzzi SpA NTZ Holds Steady at 255 as Traders Eye Resistance Oric Pharmaceuticals ORIC Holds Steady Near Key Support Levels Amidst Modest Gains Intellia Therapeutics NTLA Gains 186 as Gene Editing Stocks Find Support